Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 1/2015

01.01.2015 | Review – Cancer Research

Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies

verfasst von: Qian Feng, Yugang Chi, Yanqian Liu, Ling Zhang, Qi Liu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of our meta-analysis was to compare the efficacy and safety of radiofrequency ablation (RFA) versus surgical resection for patients with small hepatocellular carcinoma (SHCC).

Methods

Randomized controlled trials (RCTs) or retrospective studies comparing the RFA with surgical resection for patients with SHCC published from 2004 to 2014 were selected from database of PubMed, EMBASE and Cochrane library. The outcomes including overall survival rate, recurrence-free survival rate, recurrence rate and complications (mortality rate and morbidity rate) were abstracted. Individual and pooled odds ratio with 95 % confidence interval of each outcome was analyzed.

Results

Three RCTs and twenty retrospective studies were included with a total of 15,482 patients. The 1-, 3- and 5-year overall survival rate and recurrence-free survival rate of surgical resection were significantly higher than RFA. The 2- and 3-year but not 1-year recurrence rate of RFA was significantly higher than surgical resection. The morbidity rate of complication in surgical resection group was higher than it in RFA group, but the mortality was not different between the two groups.

Conclusion

Surgical resection led to a higher overall survival and recurrence-free survival rate in treating SHCC. However, RFA led to a lower morbidity rate of complication than surgical resection.
Literatur
Zurück zum Zitat Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N (2008) Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 12:1521–1526PubMedCrossRef Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N (2008) Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 12:1521–1526PubMedCrossRef
Zurück zum Zitat Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328PubMedCentralPubMedCrossRef Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328PubMedCentralPubMedCrossRef
Zurück zum Zitat Cho YK, Rhim H, Noh S (2011) Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review. J Gastroenterol Hepatol 26:1354–1360PubMed Cho YK, Rhim H, Noh S (2011) Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review. J Gastroenterol Hepatol 26:1354–1360PubMed
Zurück zum Zitat Desiderio J, Trastulli S, Pasquale R, Cavaliere D, Cirocchi R, Boselli C, Noya G, Parisi A (2013) Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 398:55–62CrossRef Desiderio J, Trastulli S, Pasquale R, Cavaliere D, Cirocchi R, Boselli C, Noya G, Parisi A (2013) Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 398:55–62CrossRef
Zurück zum Zitat Duffy JP, Hiatt JR, Busuttil RW (2008) Surgical resection of hepatocellular carcinoma. Cancer J 14:100–110PubMedCrossRef Duffy JP, Hiatt JR, Busuttil RW (2008) Surgical resection of hepatocellular carcinoma. Cancer J 14:100–110PubMedCrossRef
Zurück zum Zitat Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802PubMedCrossRef Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802PubMedCrossRef
Zurück zum Zitat Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D’Onofrio M, Martone E, Nicoli P, Iacono C (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12:192–198PubMedCrossRef Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D’Onofrio M, Martone E, Nicoli P, Iacono C (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12:192–198PubMedCrossRef
Zurück zum Zitat Guo WX, Sun JX, Cheng YQ, Shi J, Li N, Xue J, Wu MC, Chen Y, Cheng SQ (2013) Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma. World J Surg 37:602–607PubMedCrossRef Guo WX, Sun JX, Cheng YQ, Shi J, Li N, Xue J, Wu MC, Chen Y, Cheng SQ (2013) Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma. World J Surg 37:602–607PubMedCrossRef
Zurück zum Zitat Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O et al (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–729PubMedCrossRef Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O et al (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–729PubMedCrossRef
Zurück zum Zitat Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y et al (2008) Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 55:2171–2174PubMed Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y et al (2008) Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 55:2171–2174PubMed
Zurück zum Zitat Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912PubMedCrossRef Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912PubMedCrossRef
Zurück zum Zitat Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, Chiang JH, Kao WY, Huo TI, Huang YH, Su YH et al (2011) Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 9:79–86PubMedCrossRef Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, Chiang JH, Kao WY, Huo TI, Huang YH, Su YH et al (2011) Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 9:79–86PubMedCrossRef
Zurück zum Zitat Ikeda K, Kobayashi M, Kawamura Y, Imai N, Seko Y, Hirakawa M, Hosaka T, Sezaki H, Akuta N, Saitoh S et al (2011) Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model. Liver Intern 31:692–699CrossRef Ikeda K, Kobayashi M, Kawamura Y, Imai N, Seko Y, Hirakawa M, Hosaka T, Sezaki H, Akuta N, Saitoh S et al (2011) Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model. Liver Intern 31:692–699CrossRef
Zurück zum Zitat Imai K, Beppu T, Chikamoto A, Doi K, Okabe H, Hayashi H, Nitta H, Ishiko T, Takamori H, Baba H (2012) Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res 43:853–864CrossRef Imai K, Beppu T, Chikamoto A, Doi K, Okabe H, Hayashi H, Nitta H, Ishiko T, Takamori H, Baba H (2012) Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res 43:853–864CrossRef
Zurück zum Zitat Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFASG (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116:3638–3644PubMedCrossRef Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFASG (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116:3638–3644PubMedCrossRef
Zurück zum Zitat Kong WT, Zhang WW, Qiu YD, Zhou T, Bin H (2011) Prospective comparative study of cool-tip radiofrequency ablation and surgical resection for hepatocellular carcinoma. Chin-Ger J Clin Oncol 10(7):399–405CrossRef Kong WT, Zhang WW, Qiu YD, Zhou T, Bin H (2011) Prospective comparative study of cool-tip radiofrequency ablation and surgical resection for hepatocellular carcinoma. Chin-Ger J Clin Oncol 10(7):399–405CrossRef
Zurück zum Zitat Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 78(Suppl 1):113–124PubMedCrossRef Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 78(Suppl 1):113–124PubMedCrossRef
Zurück zum Zitat Li L, Zhang J, Liu X, Li X, Jiao B, Kang T (2012) Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a meta-analysis. J Gastroenterol Hepatol 27:51–58PubMedCrossRef Li L, Zhang J, Liu X, Li X, Jiao B, Kang T (2012) Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a meta-analysis. J Gastroenterol Hepatol 27:51–58PubMedCrossRef
Zurück zum Zitat Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB 9:429–434PubMedCentralPubMedCrossRef Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB 9:429–434PubMedCentralPubMedCrossRef
Zurück zum Zitat Marrero JA (2013) Multidisciplinary management of hepatocellular carcinoma: where are we today? Semin Liver Dis 33(Suppl 1):S3–S10PubMed Marrero JA (2013) Multidisciplinary management of hepatocellular carcinoma: where are we today? Semin Liver Dis 33(Suppl 1):S3–S10PubMed
Zurück zum Zitat Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC et al (2003) Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 17:1247–1261PubMedCrossRef Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC et al (2003) Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 17:1247–1261PubMedCrossRef
Zurück zum Zitat Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, et al (2011) Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 11:143PubMedCentralPubMedCrossRef Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, et al (2011) Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 11:143PubMedCentralPubMedCrossRef
Zurück zum Zitat Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS (2012) Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 262:1022–1033PubMedCrossRef Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS (2012) Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 262:1022–1033PubMedCrossRef
Zurück zum Zitat Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, et al (2013) Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma 3 cm. Results of a Multicenter Italian Survey. J Hepatol 59:89–97PubMedCrossRef Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, et al (2013) Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma 3 cm. Results of a Multicenter Italian Survey. J Hepatol 59:89–97PubMedCrossRef
Zurück zum Zitat Sung NH, Lee SY, Moon SC, Joon HL, Kwang CK, Seung WP, Byung CY, Jong CR, Choi D, Hyo KL et al (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39:247–252CrossRef Sung NH, Lee SY, Moon SC, Joon HL, Kwang CK, Seung WP, Byung CY, Jong CR, Choi D, Hyo KL et al (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39:247–252CrossRef
Zurück zum Zitat Tohme S, Geller DA, Cardinal JS, Chen HW, Packiam V, Reddy S, Steel J, Marsh JW, Tsung A (2013) Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. HPB 15:210–217PubMedCentralPubMedCrossRef Tohme S, Geller DA, Cardinal JS, Chen HW, Packiam V, Reddy S, Steel J, Marsh JW, Tsung A (2013) Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. HPB 15:210–217PubMedCentralPubMedCrossRef
Zurück zum Zitat Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H, Kagoshima Liver Cancer Study Group (2009) Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 16:359–366PubMedCrossRef Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H, Kagoshima Liver Cancer Study Group (2009) Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 16:359–366PubMedCrossRef
Zurück zum Zitat Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5–13PubMedCrossRef Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5–13PubMedCrossRef
Zurück zum Zitat Wang JH, Wang CC, Hung CH, Chen CL, Lu SN (2012) Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 56:412–418PubMedCrossRef Wang JH, Wang CC, Hung CH, Chen CL, Lu SN (2012) Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 56:412–418PubMedCrossRef
Zurück zum Zitat Wong KM, Yeh ML, Chuang SC, Wang LY, Lin ZY, Chen SC, Tsai JF, Wang SN, Kuo KK, Dai CY, et al (2012) Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma. Indian J Gastroenterol 32:253–257PubMedCrossRef Wong KM, Yeh ML, Chuang SC, Wang LY, Lin ZY, Chen SC, Tsai JF, Wang SN, Kuo KK, Dai CY, et al (2012) Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma. Indian J Gastroenterol 32:253–257PubMedCrossRef
Zurück zum Zitat Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y, Miao Y (2012) Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World J Surg Oncol 10:163PubMedCentralPubMedCrossRef Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y, Miao Y (2012) Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World J Surg Oncol 10:163PubMedCentralPubMedCrossRef
Zurück zum Zitat Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403PubMedCrossRef Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403PubMedCrossRef
Zurück zum Zitat Yun WK, Choi MS, Choi D, Rhim HC, Joh JW, Kim KH, Jang TH, Lee JH, Koh KC, Paik SW et al (2011) Superior long-term outcomes after surgery in child–pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 5:722–729PubMedCentralPubMedCrossRef Yun WK, Choi MS, Choi D, Rhim HC, Joh JW, Kim KH, Jang TH, Lee JH, Koh KC, Paik SW et al (2011) Superior long-term outcomes after surgery in child–pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 5:722–729PubMedCentralPubMedCrossRef
Zurück zum Zitat Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F, Yang J (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 10:78PubMedCentralPubMedCrossRef Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F, Yang J (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 10:78PubMedCentralPubMedCrossRef
Metadaten
Titel
Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies
verfasst von
Qian Feng
Yugang Chi
Yanqian Liu
Ling Zhang
Qi Liu
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 1/2015
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1708-1

Weitere Artikel der Ausgabe 1/2015

Journal of Cancer Research and Clinical Oncology 1/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.